Intended for healthcare professionals
Review

Expert review: current applications and future directions of artificial intelligence in obstetrics

Abstract

Artificial intelligence (AI) is rapidly transforming healthcare, with obstetrics emerging as a field of particularly high potential. This review comprehensively synthesises the current landscape of AI applications in obstetrics, critically evaluating its benefits, challenges and future directions. We conducted a systematic literature search of articles published between January 2020 and July 2025 in the PubMed, Web of Science and IEEE Xplore databases. Our analysis reveals that AI is demonstrating significant utility across the field, revolutionising areas such as prenatal ultrasound diagnosis, electronic fetal monitoring and obstetric surgical assistance. Notably, some predictive models for pregnancy complications like pre-eclampsia have achieved an area under the curve (AUC) >0.9. Despite this promise, persistent challenges include data privacy concerns, a lack of model interpretability, algorithmic bias and unresolved medico-legal issues regarding liability. Ultimately, the successful translation of AI into clinical practice hinges on both technological refinements—such as multimodal data fusion and remote monitoring—and robust governance frameworks. Addressing these ethical, legal and translational hurdles through interdisciplinary collaboration is essential for the responsible integration of AI to improve global maternal and infant health outcomes.

Introduction

Artificial intelligence (AI), a frontier technology, is transforming multiple sectors at an unprecedented pace, with the medical field being a prime example. Obstetrics is a high-risk specialty that demands time-sensitive clinical decisions. However, it currently faces several significant clinical challenges, including: limitations in imaging diagnostics that complicate fetal abnormality detection; the complex management of high-risk pregnancies due to imprecise labour monitoring; professional talent shortages coexisting with unevenly distributed medical resources; and prominent data security and privacy concerns. In recent years, AI applications have emerged in obstetrics, offering promising solutions to these challenges. The vast availability of clinical data—including ultrasound images, electronic fetal monitoring, electronic health records and genetic information—provides a foundation for AI implementation. Leveraging deep learning, machine learning and natural language processing, AI assists clinicians in early warning systems, precise diagnostics and personalised interventions, revolutionising obstetrical care. However, challenges persist, encompassing data privacy, model interpretability, ethical considerations and liability definition. This article provides an expert review of the current status, advantages and challenges of AI in obstetrics while exploring future directions, aiming to provide valuable insights for researchers and practitioners in the field.

Methods

We conducted a systematic literature search of the literature. Electronic databases including PubMed, Web of Science and IEEE Xplore were queried for articles published between January 2020 and July 2025. The search strategy used a combination of Medical Subject Headings terms and keywords: (“artificial intelligence” OR “machine learning” OR “deep learning”) AND (“obstetrics” OR “prenatal diagnosis” OR “pregnancy” OR “preeclampsia” OR “fetal monitoring” OR “labor prediction”).

Studies were included if they: (1) were original research articles, review articles or clinical trials; (2) focused on the application of AI in obstetrical care; (3) were published in English. Exclusion criteria were: (1) studies not related to clinical obstetrics; (2) editorials, letters or conference abstracts without full data; (3) non-English publications.

Two authors independently screened titles and abstracts, followed by a full-text assessment of potentially eligible articles. Data from included studies were extracted into a standardised form, capturing information on study design, population, AI methodology, key findings and limitations. Given the heterogeneity in study designs, outcomes and AI models, a narrative synthesis approach was adopted rather than a meta-analysis.

Overview of artificial intelligence technology

AI is a science that studies how to simulate human intelligence, aiming to enable computers to possess the abilities to perceive, reason, learn and make decisions like humans.1–3 Machine learning and deep learning are the two core branches of AI. Machine learning relies on feature engineering and manually designed data representation methods, focusing on building specific algorithm models (such as decision trees, support vector machines, random forests) to learn patterns from manually designed features and complete prediction tasks. Deep learning, based on multilayer neural networks, emphasises end-to-end automatic learning of multilevel abstract feature representations from raw data and is suitable for processing complex data types such as images, speech, text and time series.4 AI technology possesses adaptability, efficiency and the capability for intelligent decision-making. It can process large quantities of complex data, optimise model performance and offer solutions to intricate problems.5 6 In the medical field, AI has been widely used in medical imaging diagnosis, disease prediction, drug research and development, and surgical assistance, significantly enhancing diagnostic efficiency and accuracy, and optimising the allocation of medical resources.

Specific applications of artificial intelligence in obstetrics

Pregnancy monitoring and risk assessment

In the field of perinatal medicine, preterm birth, gestational diabetes mellitus (GDM) and pre-eclampsia (PE) are common complications that seriously affect maternal and infant health. AI technology can develop risk prediction models for these complications by deeply analysing multidimensional data (such as personal and family medical history, age, weight, blood pressure, blood sugar, lifestyle).7 8 Table 1 summarises key studies that have explored these applications of AI. Furthermore, AI demonstrates utility in predicting long-term outcomes such as the risk of postpartum progression to type 2 diabetes among patients with GDM.9

Table 1
AI applications in pre-eclampsia prediction and management

Early screening and management of pre-eclampsia

PE is a severe disease unique to pregnancy and is one of the main causes of morbidity and mortality in pregnant women and perinatal infants. In recent years, AI technology has shown great potential in the prediction, diagnosis and management of PE [area under the curve (AUC)>0.9].10 For instance, the research team from Sun Yat-sen University employed AI deep learning algorithms to construct the PROMPT prediction model, which is based on retinal vascular features. This model achieved an AUC of up to 0.87 for predicting PE and an accuracy rate of up to 0.91 for predicting preterm PE.11 Additionally, machine learning models have significantly enhanced the accuracy of predicting PE by incorporating routine blood test data and clinical features. A model developed by a Brazilian study, which used synthetic data enhancement technology, achieved an accuracy rate of 90.6% (AUC=0.832) by considering parameters such as haemoglobin and liver function indicators.12 13 These technologies can identify high-risk pregnant women in advance and provide decision support for clinical doctors, thereby reducing the incidence of complications such as preterm birth and GDM, and ultimately improving pregnancy outcomes.

Value of artificial intelligence in labour prediction

Recent studies consistently indicate that AI in obstetrical decision support holds significant clinical potential for predicting the course of labour. Liu et al developed second-stage duration models using 1-hour and 2-hour thresholds. In the testing set, the 1-hour model achieved an AUC of 0.808, while the 2-hour model reached a higher AUC of 0.824, indicating strong discriminative performance for both.14 When dynamic intrapartum features such as the duration of the first stage, uterine contractions and fetal position are incorporated, the explanatory power for predicting the duration of the second stage is substantially enhanced.14 Fernández et al used a comprehensive clinical database containing 48 attributes to develop models predicting mode of delivery (caesarean section, eutocic vaginal delivery and instrumental vaginal delivery) with machine learning algorithm.15 In the caesarean versus vaginal delivery discrimination, all three models achieved overall accuracy at or above 90%, while discrimination between instrumental and vaginal deliveries approached 87%.15 Labour duration prediction tools offer potential clinical utility for real-time labour monitoring, determining whether to continue vaginal delivery or to initiate caesarean delivery earlier, and guiding resource allocation and delivery pathways. However, multiple studies emphasise the necessity of cross-institution external validation and local calibration to ensure reproducibility and safety across diverse patient populations and settings.14 16 17

Application of artificial intelligence in preterm birth

Preterm birth is one of the primary causes of perinatal infant mortality and long-term health issues globally, with an incidence rate of approximately 10%.18 In recent years, AI technology has demonstrated significant potential in predicting, preventing and managing preterm births. By analysing multidimensional data, (such as medical history, age, weight, lifestyle, genetic factors and biomarkers of pregnant women), AI can construct preterm birth risk prediction models. This enables the identification of high-risk pregnancies in advance, offering opportunities for early clinical intervention. For instance, researchers employed machine learning algorithms to analyse biomarkers, including inflammatory factors and hormone levels, in the blood samples of pregnant women. They combined this with clinical data, such as pregnancy history and pregnancy complications, to develop models capable of accurately predicting the risk of preterm birth.19 Additionally, AI technology can be used for real-time monitoring during pregnancy. By employing wearable devices and mobile medical technology, it can gather physiological data from pregnant women in real-time (including heart rate, blood pressure, uterine contraction frequency), analyse this data and promptly detect abnormal conditions, issuing alerts when necessary.20 As AI technology continues to evolve and data accumulates, its application in preventing and managing preterm birth is expected to expand and deepen. This development could significantly reduce the incidence of preterm births, enhance the prognosis for preterm infants and protect the health of both mothers and infants.

Prenatal ultrasound examination

Ultrasound examination is an important method for prenatal screening, yet traditional ultrasound examinations have issues such as reliance on the operator’s experience and the subjectivity of image interpretation. The integration of AI has led to significant advancements in ultrasound examination. For instance, in cleft lip detection, studies have shown that AI algorithms incorporating spatiotemporal facial features can achieve an accuracy of 88%, an improvement over models relying solely on static features (84%).21 22 Furthermore, AI technology can automatically measure fetal biometric parameters and analyse them to more accurately estimate fetal weight and gestational age, and promptly identify issues such as fetal growth retardation or excessive growth.23 24 AI can also assist in identifying the structure of each fetal organ, aiding doctors in more accurately detecting whether fetuses have organ malformations or developmental abnormalities.25

Electronic fetal monitoring

Electronic fetal monitoring is an essential tool for assessing the condition of fetuses in utero; however, traditional methods depend heavily on the expertise of doctors and are susceptible to human error. AI technology offers a more objective and precise approach to fetal monitoring. For instance, a hybrid model that combines one-dimensional convolutional neural network (1D-CNN) and bidirectional gated recurrent unit (GRU) can process fetal monitoring data in real-time with an accuracy exceeding 95%.26 AI technology can promptly identify potential abnormal conditions, such as fetal hypoxia, and significantly enhance the early warning capability for fetal distress in utero. Furthermore, AI technology can predict the risk of fetal acidosis by conducting in-depth analyses of trends and characteristics in fetal heart rate changes, offering an accurate basis for clinical decision-making by doctors.27

Obstetric surgical assistance

In the field of obstetric surgery, including caesarean sections, AI technology is increasingly playing a significant role. It can perform precise three-dimensional reconstructions and surgical planning based on patients’ imaging data, offering doctors intuitive and accurate surgical plans.28 In robotic surgery, AI uses computer vision technology to accurately identify anatomical landmarks in real-time, thereby reducing the risk of surgical injury.29 Additionally, AI technology can analyse images and data in real-time during surgery, offering real-time surgical guidance and suggestions to doctors, thereby enhancing the accuracy and safety of the procedure.30

Advantages and challenges of artificial intelligence in obstetrics

AI offers significant advantages in obstetric healthcare. First, it can process and analyse vast quantities of data swiftly, minimising the influence of human factors. This greatly enhances the accuracy and reliability of diagnoses and aids in the early identification and diagnosis of various obstetrical diseases and abnormal conditions.31 Second, AI can develop personalised treatment plans for each patient, enhancing treatment effectiveness and the quality of life for patients.32 Furthermore, AI offers scientific and objective decision-making support to doctors, aiding in the development of more rational treatment plans, reducing medical risks and enhancing medical quality.33

Despite the significant potential of AI in obstetrics, its application continues to encounter numerous challenges. Initially, AI necessitates substantial data support; however, the quality and integrity of this data are vital for model performance. Nevertheless, patients’ medical data encompasses personal privacy. Consequently, the collection, storage and utilisation of data while guaranteeing data security pose a major challenge at present.34 Limitations in AI technology persist, including insufficient model interpretability (‘black box’ nature), limited generalisability to rare cases or diverse populations and potential algorithmic bias, which may impact its effectiveness and trustworthiness in clinical practice.35 Additionally, the definition of medical liability urgently needs resolution: during the process of AI-assisted diagnosis and treatment, determining the attribution of liability in the event of a medical accident or misdiagnosis remains a legal challenge. Simultaneously, the application of AI in obstetrics has raised a series of ethical issues, including patient privacy protection, cybersecurity and data transparency. These concerns necessitate thorough discussion and regulation as the technology is implemented.36

Future development directions of artificial intelligence in obstetrics

Further deepening and integration of technology

In the future, the application of AI in obstetrics will evolve towards greater intelligence and precision. The integration of deep learning with reinforcement learning will emerge as a significant technological trend, enhancing the capabilities of AI systems to address complex obstetrical challenges. Concurrently, multimodal data fusion will become a key development area. Through the integration of diverse data types, AI systems can achieve a more comprehensive understanding of maternal and infant health, significantly boosting the accuracy of diagnoses and predictions.

Expansion and deepening of clinical applications

With the advancement of Internet of Things technology, it is anticipated that remote, real-time monitoring of pregnant women and fetuses will be achievable through wearable devices in the future. When combined with the intelligent early warning capabilities of AI technology, this will enable the timely identification of abnormal situations and prompt notification to both doctors and pregnant women. Consequently, the quality and efficiency of perinatal healthcare are expected to improve significantly. Furthermore, leveraging the powerful analytical capabilities of AI, more accurate diagnoses and interventions for obstetric diseases could be possible at an early stage in the future, thereby enhancing the prognosis for both mothers and infants.

Talent cultivation and interdisciplinary integration

The application of AI in obstetrics necessitates professionals with a blend of medical expertise, computer technology skills and data analysis capabilities. In the future, it will be essential to enhance the training of interdisciplinary professionals and foster the integration of medicine, computer science, mathematics and other fields to provide robust talent support for the ongoing development of AI in obstetrics. Concurrently, it is also crucial to reinforce collaboration and communication between clinical physicians and data scientists.

Development of medical AI governance system

In terms of ethical norms, there are numerous gaps in the current medical ethics review standards within the field of AI healthcare, which fail to comprehensively address the ethical issues arising from the application of AI technology.

To address these challenges and ensure that ethical considerations are fully integrated into the development and deployment of AI systems, we recommend a set of practical strategies encompassing public policy, digital governance, professional training and rigorous ethical review.37 First, a clear regulatory framework must be established, defining standards for data security, patient privacy, clinical responsibility and algorithmic governance, referencing and adhering to relevant regulations such as health insurance portability and accountability act (HIPAA), general data protection regulation (GDPR) and the provisional measures for the management of generative artificial intelligence services.38–41 Second, healthcare institutions and public sectors should establish multidisciplinary AI ethics review boards, comprising healthcare professionals, technology experts, ethicists, legal experts and patient representatives, to ensure the comprehensiveness and representativeness of ethical reviews.42 43 These boards should be responsible for reviewing AI applications, focusing on issues such as informed consent for using prenatal data in AI models, mitigating algorithmic bias that could disproportionately affect certain demographic groups, ensuring equitable access to AI-enhanced care and defining protocols for disclosing AI-driven findings to patients.

Conclusion

AI is profoundly transforming obstetrical care, with significant potential to enhance efficiency, precision and accessibility. Current applications span the entire spectrum of prenatal, intrapartum and postpartum care, particularly in image analysis, risk prediction and automated monitoring. However, challenges persist, including data scarcity and heterogeneity, limited model generalisability, lack of algorithm transparency, ethical and legal issues and clinical integration. Future directions include multimodal fusion, privacy-preserving computing, interpretability enhancement, real-time dynamic monitoring and personalised precision interventions. Driving high-quality clinical research, strengthening interdisciplinary collaboration (medicine-engineering-ethics-policy) and establishing a robust regulatory framework are key to unleashing the full potential of AI in obstetrics and ultimately paving the way for a new era of data-driven, personalised and equitable obstetric care.

  • Contributors: All authors have made substantial contributions to this work and meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship. The specific contributions are outlined as follows: FH: Conceptualisation, Methodology, Writing—Original Draft. DC: Writing—Review and Editing, Funding Acquisition. All authors have read and agreed to the published version of the manuscript.

  • Funding: This work was supported by the Guangzhou Key Research and Development Plan: Agricultural and Social Development Technology Special Topic Project (2024B03J1289).

  • Competing interests: DC has served as an editorial member of GOCM. All other authors declare no competing interest.

  • Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review: Not commissioned; externally peer reviewed.

Ethics statements

Patient consent for publication:
Ethics approval:

Not applicable.

  1. close Manickam P, Mariappan SA, Murugesan SM, et al. Artificial intelligence (AI) and internet of medical things (IoMT) assisted biomedical systems for intelligent healthcare. Biosensors (Basel) 2022; 12.
  2. close Singh S, Kaur N, Gehlot A, et al. Application of artificial intelligence in drug design: A review. Comput Biol Med 2024; 179:108810.
  3. close Lombrozo T. Learning by thinking in natural and artificial minds. Trends Cogn Sci (Regul Ed) 2024; 28:1011–22.
  4. close Zhao X, Bai J-W, Guo Q, et al. Clinical applications of deep learning in breast MRI. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878:188864.
  5. close Nozaki T, Hashimoto M, Ueda D, et al. Recent topics in musculoskeletal imaging focused on clinical applications of AI: How should radiologists approach and use AI? Radiol Med 2025; 130:587–97.
  6. close Liu J, Xiao H, Fan J, et al. An overview of artificial intelligence in medical physics and radiation oncology. J Natl Cancer Cent 2023; 3:211–21.
  7. close Wang C, Johansson ALV, Nyberg C, et al. Prediction of pregnancy-related complications in women undergoing assisted reproduction, using machine learning methods. Fertil Steril 2024; 122:95–105.
  8. close Ravindra NG, Espinosa C, Berson E, et al. Deep representation learning identifies associations between physical activity and sleep patterns during pregnancy and prematurity. Npj Digit Med 2023; 6:171.
  9. close Belsti Y, Moran LJ, Goldstein R, et al. Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) study. Clin Nutr 2024; 43:1728–35.
  10. close Kasartzian D-I, Tsiampalis T. Transforming cardiovascular risk prediction: A review of machine learning and artificial intelligence Innovations. Life (Basel) 2025; 15.
  11. close Wu Y, Shen L, Zhao L, et al. Noninvasive early prediction of preeclampsia in pregnancy using retinal vascular features. NPJ Digit Med 2025; 8.
  12. close Araújo DC, de Macedo AA, Veloso AA, et al. Complete blood count as a biomarker for preeclampsia with severe features diagnosis: a machine learning approach. BMC Pregnancy Childbirth 2024; 24.
  13. close Bülez A, Hansu K, Çağan ES, et al. Artificial intelligence in early diagnosis of preeclampsia. Niger J Clin Pract 2024; 27:383–8.
  14. close Huang X, Di X, Lin S, et al. Artificial intelligence-based prediction of second stage duration in labor: a multicenter retrospective cohort analysis. eClinicalMedicine 2025; 80:103072.
  15. close De Ramón Fernández A, Ruiz Fernández D, Prieto Sánchez MT, et al. Prediction of the mode of delivery using artificial intelligence algorithms. Comput Methods Programs Biomed 2022; 219:106740.
  16. close Owusu-Adjei M, Ben Hayfron-Acquah J, Frimpong T, et al. An AI-based approach to predict delivery outcome based on measurable factors of pregnant mothers. PLOS Digit Health 2025; 4.
  17. close Hu T, Du S, Li X, et al. Establishment of a model for predicting the outcome of induced labor in full-term pregnancy based on machine learning algorithm. Sci Rep 2022; 12.
  18. close Ding L, Yin X, Wen G, et al. Prediction of preterm birth using machine learning: a comprehensive analysis based on large-scale preschool children survey data in Shenzhen of China. BMC Pregnancy Childbirth 2024; 24.
  19. close Al Ghadban Y, Du Y, Charnock‐Jones DS, et al. Prediction of spontaneous preterm birth using supervised machine learning on metabolomic data: A case–cohort study. BJOG 2024; 131:908–16.
  20. close Liu L, Pu Y, Fan J, et al. Wearable sensors, data processing, and artificial intelligence in pregnancy monitoring: A review. Sensors (Basel) 2024; 24:6426.
  21. close Hayajneh A, Serpedin E, Stotland MA, et al. Facial anomaly appraisal using discrepancy optimization-driven automatic inpainting. IEEE J Biomed Health Inform 2025; PP.
  22. close Alsuhaibani M, Dodge HH, Mahoor MH, et al. Mild cognitive impairment detection from facial video interviews by applying spatial-to-temporal attention module. Expert Syst Appl 2024; 252:124185.
  23. close Gao Z, Tian Z, Pu B, et al. Deep endpoints focusing network under geometric constraints for end-to-end biometric measurement in fetal ultrasound images. Comput Biol Med 2023; 165:107399.
  24. close Farsetti D, Barbieri M, Magni E, et al. The role of umbilical vein blood flow assessment in the prediction of fetal growth velocity and adverse outcome: a prospective observational cohort study. Am J Obstet Gynecol 2025; 233:66.
  25. close Taksøe‐Vester CA, Mikolaj K, Petersen OBB, et al. Role of artificial‐intelligence‐assisted automated cardiac biometrics in prenatal screening for coarctation of aorta. Ultrasound in Obstet & Gyne 2024; 64:36–43.
  26. close Liang H, Lu Y. A CNN-RNN unified framework for intrapartum cardiotocograph classification. Comput Methods Programs Biomed 2023; 229:107300.
  27. close McCoy JA, Levine LD, Wan G, et al. Intrapartum electronic fetal heart rate monitoring to predict acidemia at birth with the use of deep learning. Am J Obstet Gynecol 2025; 232:116.
  28. close Vasey B, Lippert KAN, Khan DZ, et al. Intraoperative applications of artificial intelligence in robotic surgery: A scoping review of current development stages and levels of autonomy. Ann Surg 2023; 278:896–903.
  29. close Varghese C, Harrison EM, O’Grady G, et al. Artificial intelligence in surgery. Nat Med 2024; 30:1257–68.
  30. close Goodman ED, Patel KK, Zhang Y, et al. Analyzing surgical technique in diverse open surgical videos with multitask machine learning. JAMA Surg 2024; 159:185.
  31. close Lei T, Zheng Q, Feng J, et al. Enhancing trainee performance in obstetric ultrasound through an artificial intelligence system: randomized controlled trial. Ultrasound in Obstet & Gyne 2024; 64:453–62.
  32. close Hernández-Arango A, Arias MI, Pérez V, et al. Prediction of the risk of adverse clinical outcomes with machine learning techniques in patients with noncommunicable diseases. J Med Syst 2025; 49.
  33. close Li Y, Ren H, Chi C, et al. Artificial intelligence‐guided Gut‐microenvironment‐triggered imaging sensor reveals potential indicators of Parkinson’s disease. Adv Sci (Weinh) 2024; 11:2307819.
  34. close Koutsoubis N, Waqas A, Yilmaz Y, et al. Privacy-preserving federated learning and uncertainty quantification in medical imaging. Radiol Artif Intell 2025; 7.
  35. close Farinella R, Felici A, Peduzzi G, et al. From classical approaches to artificial intelligence, old and new tools for PDAC risk stratification and prediction. Semin Cancer Biol 2025; 112:71–92.
  36. close Theriault-Lauzier P, Cobin D, Tastet O, et al. A responsible framework for applying artificial intelligence on medical images and signals at the point of care: The PACS-AI platform. Can J Cardiol 2024; 40:1828–40.
  37. close dos Santos GG. Using artificial intelligence as a technological tool in gynecologic and obstetric health: A narrative literature review. Intl J Gynecology & Obste 2025;
  38. close von Gerich H, Moen H, Block LJ, et al. Artificial Intelligence -based technologies in nursing: A scoping literature review of the evidence. Int J Nurs Stud 2022; 127:104153.
  39. close Cohen IG, Mello MM. HIPAA and protecting health information in the 21st Century. JAMA 2018; 320:231.
  40. close Voigt P, von dem Bussche A. The EU general data protection regulation (GDPR), A Practical Guide. Cham, Springer International Publishing 2017; 10:10–5555.
    Available: here
  41. close TRANSLATE CL. Interim measures for the management of generative artificial intelligence services (2023)(translation). 2023;
  42. close Ramakrishnan R, Rao S, He J-R, et al. Perinatal health predictors using artificial intelligence: A review. Womens Health (Lond Engl) 2021; 17:17455065211046132.
  43. close Mennickent D, Rodríguez A, Opazo MC, et al. Machine learning applied in maternal and fetal health: a narrative review focused on pregnancy diseases and complications. Front Endocrinol (Lausanne) 2023; 14.

Crossmark logoCrossmark logo
  • Received: 27 July 2025
  • Accepted: 23 October 2025
  • First published: 10 November 2025

Altmetric

Altmetric scores reflect online attention articles receive, shown as a central number with coloured threads for each source

Dimensions

Dimensions shows where and when an article has been cited, helping readers understand its academic influence over time